Please Wait
Applying Filters...
menu
    • menu
    Minakem delivers API, HPAPI, steroids & CDMO services for generics with FDA/GMP certification, regulatory know-how & proven success.

    Virtual Booth

    Contact Supplier

    Boai NKY Pharmaceuticals Ltd. is one of the largest global PVP suppliers.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-04-20

    Virtual Booth

    An Enquiry

    Nanjing Well is focused on R&D, production & sales of Pharmaceutical Excipients & Synthetic Lubricating base oils.

    Virtual Booth

    Contact Supplier

    Ever Pharma, highly specialized CDMO in producing complex injectables including high potency & controlled substances, suspensions, etc.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2026-04-20

    Virtual Booth

    An Enquiry

    Menu

    Umeclidinium and vilanterol

    DEVELOPMENTS

    DIGITAL CONTENT

    PharmaCompass
    Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    FDA Accepts Transpire Bio's ANDA for Generic Trelegy® Ellipta®
    FDA Accepts Transpire Bio's ANDA for Generic Trelegy® Ellipta®

    11 May 2026

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/transpire-bios-anda-for-generic-high-strength-trelegy-ellipta-accepted-for-filing-by-the-us-fda-302767387.html

    PR NEWSWIRE
    11 May 2026
    Share Share
    Gsk's Trelegy Ellipta Approved In China For Uncontrolled Asthma
    Gsk's Trelegy Ellipta Approved In China For Uncontrolled Asthma

    28 Jan 2026

    // INDPHARMAPOST

    https://www.indianpharmapost.com/news/trelegy-ellipta-gets-green-light-in-china-for-adults-with-uncontrolled-asthma-18976

    INDPHARMAPOST
    28 Jan 2026
    Share Share
    U.S. FDA Accepts Transpire Bio's ANDA for Generic Trelegy Filing
    U.S. FDA Accepts Transpire Bio's ANDA for Generic Trelegy Filing

    27 Jan 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/01/27/3226303/0/en/Transpire-Bio-s-ANDA-for-Generic-Trelegy-Ellipta-Accepted-for-Filing-by-the-U-S-FDA.html

    GLOBENEWSWIRE
    27 Jan 2026
    Share Share
    Transpire Bio's Generic Breo Ellipta Anda Accepted By Us FDA
    Transpire Bio's Generic Breo Ellipta Anda Accepted By Us FDA

    23 Sep 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/09/23/3154541/0/en/Transpire-Bio-s-ANDA-for-Generic-Breo-Ellipta-Accepted-for-Filing-By-the-U-S-FDA.html

    GLOBENEWSWIRE
    23 Sep 2025
    Share Share
    GSK’s Trelegy Ellipta: US FDA Panel To Weigh Role Of Inhaled Corticosteroids
    GSK’s Trelegy Ellipta: US FDA Panel To Weigh Role Of Inhaled Corticosteroids

    27 Aug 2020

    // PINKSHEET

    https://pink.pharmaintelligence.informa.com/PS142810/GSKs-Trelegy-Ellipta-US-FDA-Panel-To-Weigh-Role-Of-Inhaled-Corticosteroids-On-Mortality-Results

    PINKSHEET
    27 Aug 2020
    Share Share
    GSK filing accepted by EMA for Trelegy Ellipta use in adult patients with asthma
    GSK filing accepted by EMA for Trelegy Ellipta use in adult patients with asthma

    27 Feb 2020

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20200227005586/en

    BUSINESSWIRE
    27 Feb 2020
    Share Share
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.